5-Fluoro-AMT
group of stereoisomers
5-Fluoro-αMT, also known as 5-fluoro-α-methyltryptamine (5F-AMT) or by its developmental code names PAL-212 and PAL-544, is a monoaminergic drug of the tryptamine and α-alkyltryptamine families related to α-methyltryptamine (αMT). It is taken orally.
The drug is known to act as a serotonin receptor agonist, monoamine releasing agent, and potent monoamine oxidase inhibitor. It produces psychedelic- and stimulant-like effects in animals. 5-Fluoro-AMT is also known to be psychoactive in humans, though its effects have not been well-described.
5-Fluoro-AMT was first described in the scientific literature by 1963. There has been interest in 5-fluoro-AMT as a possible treatment for cocaine dependence.
Use and effects
5-Fluoro-AMT has been said to be psychoactive in humans at a dose of 25 mg orally, although the qualitative nature of these effects has not been well-described. Preclinical studies suggest that 5-fluoro-αMT may be a psychedelic, stimulant, and/or entactogen in humans. However, 5-fluoro-AMT may be dangerous in humans due to its concomitant potent monoamine oxidase inhibition.
The public source identifies “5-Fluoro-AMT” as group of stereoisomers. This brief keeps that definition visible, then builds a research path around 5-Fluoro-AMT, group and stereoisomers.
Why this record matters
A short description can identify a subject without explaining its stakes. For “5-Fluoro-AMT”, the useful work is to connect “group of stereoisomers” to the records capable of establishing context and consequence.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Feb 15, 2026. The linked authority identifier is Q4639589. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1963.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “5-Fluoro-AMT”, its source revision and the description used here.
- Expand the search: follow 5-Fluoro-AMT primary sources, 5-Fluoro-AMT archive and 5-Fluoro-AMT research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “5-Fluoro-AMT”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “5-Fluoro-AMT” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.